Сervical cancer’s epidemiology in the Republic of Kazakhstan and in the world. Impact of population adherence on coverage and success of cervical cancer screening programs
DOI:
https://doi.org/10.37800/RM2021-2-2Keywords:
cervical cancer, screening, adherence, coverageAbstract
For many years, the problem of the prevalence of cervical cancer has been one of the most pressing for public health in most countries of the world. Despite the increasing number of screening programs, cervical cancer is still one of the most common sites of malignant neoplasms of the female reproductive system. Screening programs are effective if they involve 70% or more of the population in the appropriate age groups. In Kazakhstan, this figure for cervical cancer screening is 48-50%. [1,2,3]
References
Dannyie Vsemirnoy organizatsii zdravoohraneniya. Skrining na rak sheyki matki (https://www.who.int/cancer/detection/cytologyscreen/ru/)
Shalabekova M.T., Kudaybergenova T.A. Vestnik Almatinskogo gosudarstvennogo instituta usovershenstvovaniya vrachey.2018; 3: 67–75
Bekmuhambetov E.Zh., Balmagambetova S.K., Zhyilkaydarova A.Zh. Onkologiya i radiologiya Kazahstana. 2017; 2(44): 30-33
Amerikanskoe onkologicheskoe obschestvo . Globalnyie faktyi i tsifryi o rake. 2-e izd. (http://www.cancer.org/acs/groups/content/@epidemiologysurveilance/documents/document/acspc‐027766.pdf. Accessed 10 iyunya, 2016
Dannyie Kazahsko nauchno-issledovatelskogo instituta onkologii i radiologii (https://onco.kz/skrining-na-rannee-vyyavlenie-raka-molochnoj-zhelezy)
YuNFPA «Kompleksnyie programmyi profilaktiki i snizheniya zabolevaemosti rakom sheyki matki Rukovodstvo dlya gosudarstv», Fevral 2011 g
Gintsburg O.M. Borba s rakom molochnoy zhelezyi i sheyki matki v stranah s nizkim i srednim urovnem dohoda: prava cheloveka sootvetstvuyut razumnoy politike zdravoohraneniya. Politika J Canc. 2013; 1(3–4): e35e41.
Uolsh B., Sills M., O’Neyl C. Rol chastnogo meditsinskogo strahovaniya v sotsialno-ekonomicheskom neravenstve pri skrininge raka v Irlandii. Ekon. Zdorovya. 2012; 21: 1250–1256.
Shamsutdinova A.G., Turdalieva B.A., Ramazanova B.A., Beltenova A.G. Sibirskiy onkologicheskiy zhurnal. 2020; 19(4): 7–23
Lim D.U., Oyo A.A. Eur J Cancer Care. 2017; 26(1): e12444.
Marlow L.V., Wardle J., Waller J. BJC. 2015;113: 833–839.
Review of the cervical cancer burden and population-based cervical cancer screening in China
Ferley Dzh., Surdzhomataram I., Ervik M., Dikshit R., Ezer S., Mazers K., Rebelo M., Parkin D. M., Forman D., Brey F. GLOBOCAN 2012 v1.Onkologicheskaya baza MAIR # 11, Lion : Mezhdunarodnoe agentstvo po izucheniyu raka; 2014 g.
Kelias Firi Msyamboza 1 2, Twambilire Phiri 3, Uesli Sihali 4, Villi Kvenda 5, Fanni Kachale BMC Public Health. 2016 17 avgusta; 16 (1): 806. https://doi.org/10.1186/s12889-016-3530-u
Atashili J, Smith JS, Adimora AA, Eron J, Miller WC, Myers E. PLoS One. 2011;6(4), e18527. 11.
Li R, Lewkowitz AK, Zhao FH, Zhou Q, Hu SY, Qiu H, Zhang Y, Jiang HW, Zhang JS, Li M, Tong SM, Zhang QY, Qiao YL. Arch Gynecol Obstet. 2012;285(6):1627–32.
Syuzanna M. Garland , Nirdzha Bhatla i Hekstan I.S. Ngan DOI: 10.1158 /1055-9965.EPI-12-0164 sentyabr 2012g.
Rogovskaya S. I., Mashovets S. P., Moskvina N. B. [i dr.] Doktor.Ru. 2016 # 8 (125) — # 9 (126). S. 6–10.
Радзинский В.Е. Слово главного редактора // Status Praesens. 2017.- N2(38).- С.10.
Rogovskaya S. I., Gerasimenko M.Yu., Mashovets SP [i dr.] Rossiysko-kitayskiy nauchnyiy zhurnal «Sodruzhestvo» 2016; 5 (5): 29-35.
Perova M. Izdatelskiy dom «Uromedia». 2016; 2: 6-14
Vesna Keshich , Mario Polyak i Svetlana Rogovskaya DOI: 10.1158 / 1055-9965.EPI-12-0181, sentyabr 2012 g.
Mezhdunarodnoe agentstvo po izucheniyu raka. Skrining raka sheyki matki. V: Spravochniki MAIR po profilaktike raka. Vol. 10. Lion, Frantsiya : IARC Press ; 2005 . p. 1 – 302.
Marc Arbyn Evropeyskiy zhurnal po seksualnomu i reproduktivnomu zdorovyu No.64 – 2007
Aymon P. Cervical cancer screening: some evidence coming from the north // Cancer J. 1987; 1: 342.
Coleman D.V. The dynamics of the cervical screening programme // Experts’ Conference of 2nd International Congress of
Papillomavirus in Human Pathology/ Ed. by J. Monsonego- Paris- EUROGIN Sci. Publ.- 1994- P.21-25.
Sh. Nurgaziev Rannyaya diagnostika raka sheyki matki na urovne pervichnoy mediko-sanitarnoy pomoschi. Tsitologicheskiy skrining. Metodicheskie rekomendatsii. Almatyi: 2012. 364 s.
D.R. Kaydarova, M.R. Kayrbaeva, R.O. Bolatbekova «Epidemiologiya Raka Sheyki Matki v Respublike Kazahstan Za 10 let», 2017g.
Kaydarova D.R., Kayrbaev M.R., Bolatbekova R.O. Onkologiya i radiologiya Kazakhstana. – 2017. - # 43 (1). – S. 7-11.
Kaydarova D.R. Оpyt skrininga raka sheyki matki v respublike Kazakhstan. EURASIAN CANCER SCREENING CONFERENCE, 2018g
Kasyimova G.P., Shalkarbaeva N.Zh. Vestnik KazNMU. 2015; 3: 107–108.
Shalgumbaeva G.M., Sagidullina G.G., Sandyibaev M.N.,Musahanova A.K., Semenova L.M., Kaydarova S.B., Slyamhanova N.S.,Adieva M.K., Zhumyirbaeva N.A., Sadyibekova Zh.T. Nauka i zdravoohranenie. 2014; 2: 55
Goldhaber-Fiebert JD, Denny LA, De Souza M, Kuhn L, Goldie SJ (2009). PLoS ONE 4 (5): e5691. https://doi.org/10.1371/journal.pone.0005691
Additional Files
Published
How to Cite
Issue
Section
License
The articles published in this Journal are licensed under the CC BY-NC-ND 4.0 (Creative Commons Attribution – Non-Commercial – No Derivatives 4.0 International) license, which provides for their non-commercial use only. Under this license, users have the right to copy and distribute the material in copyright but are not permitted to modify or use it for commercial purposes. Full details on the licensing are available at https://creativecommons.org/licenses/by-nc-nd/4.0/.
